SHERIDAN, WYOMING – October 21, 2025 – The global sports, leisure, and public space industries are preparing for a major milestone event as FSB 2025, the International Trade Fair for Public Space, Sports, and Leisure Facilities, opens its doors in Cologne from October 28 to 31, 2025. Poised to be the world’s largest gathering in its sector, this year’s edition underscores the industry’s rebound and innovation drive, highlighting sustainable urban planning, digital infrastructure, and inclusive design across more than 70,000 square meters of exhibition space.

A Record-Breaking Year for Exhibitor Participation

SHERIDAN, WYOMING – October 15, 2025 – Diebold Nixdorf (NYSE: DBD), a global technology leader in connected commerce for banking and retail, has announced two key executive appointments aimed at unifying commercial operations and strengthening administrative efficiency worldwide. Joe Myers will become Chief Revenue Officer (CRO) starting January 1, 2026, while Elizabeth (Lisa) Radigan will assume the newly created role of Chief Administrative Officer (CAO) effective December 1, 2025.

Both appointments reflect Diebold Nixdorf’s continued focus on integrated growth strategies, cross-segment collaboration, and scalable operational models designed to support banks and retailers adapting to rapid digital transformation.

Unifying Sales to Drive Customer-Centric Growth

SHERIDAN, WYOMING – October 15, 2025 – SIPA is charting the future of refillable PET packaging with the debut of its XTRA 8 rotary blowmolder at Drinktec 2025, introducing an advanced, digitally intelligent platform that blends speed, sustainability, and precision engineering. Designed for the next generation of returnable bottle systems, the XTRA 8 positions SIPA as a frontrunner in the race toward smarter and greener beverage production.

SHERIDAN, WYOMING – October 15, 2025 – SIPA, a global leader in PET packaging and bottling technology, has introduced its new XLABL RF rotary roll-fed labeller — a breakthrough that completes the company’s fully integrated Sincro Tribloc System. This new machine enables a unified production flow from blowing and filling to labelling, achieving record-setting speeds of up to 90,000 bottles per hour.

A Fully Integrated Bottling Workflow for Modern Production Lines
The addition of the XLABL RF transforms SIPA’s Sincro Tribloc into a fully synchronized, closed-loop solution that minimizes complexity, reduces downtime, and elevates output efficiency. By integrating the labelling phase directly into the production sequence, manufacturers can streamline their operations without sacrificing precision or consistency.

SHERIDAN, WYOMING – October 15, 2025 – SIPA has unveiled the XFORM PRO, a next-generation PET preform system that merges mechanical innovation with digital intelligence. Building on the success of the XFORM Gen 4, the new platform delivers faster cycles, lower energy use, and seamless integration with the company’s new XBrain telemetric mold management system—marking a major leap forward in high-cavitation PET preform manufacturing.

SHERIDAN, WYOMING – October 15, 2025 – Italian packaging technology leader SIPA has introduced the new XFORM 160, a smart and scalable preform production system that targets low- to mid-volume bottlers and converters seeking high performance without high complexity. Positioned as the entry-level model in SIPA’s now fully integrated XFORM lineup—which includes the 160, 250, 350, and 500 systems—the machine marks a strategic move to make advanced preform manufacturing accessible to a broader range of producers.

Smart, Sustainable, and Scalable Performance
The XFORM 160 is designed to meet the shifting needs of a dynamic packaging market where sustainability, agility, and modular growth are key. With a compact footprint and plug-and-play setup, the system enables rapid installation and adaptability for small-scale bottlers, specialty converters, and new entrants to the PET packaging segment.

SHERIDAN, WYOMING – October 15, 2025 – SIPA has introduced the Sincro Tribloc, a fully integrated PET bottling solution that combines blowing, labelling, and filling in one compact unit. Designed for ultra-high-speed operations of up to 90,000 bottles per hour, the system redefines efficiency and sustainability standards for beverage manufacturers seeking leaner production and reduced total cost of ownership.

SHERIDAN, WYOMING – October 15, 2025 – Italian engineering firm SIPA has unveiled the ECS SP130, a next-generation Injection-Stretch-Blow Molding (ISBM) system that marks a major leap forward in packaging production. Designed entirely in Italy, the new machine is built to set a new global benchmark for productivity, quality, and operational versatility in the manufacturing of plastic containers.

Reinventing Performance and Clean Production Standards
The ECS SP130 is engineered to meet the most demanding industrial environments. Capable of handling blow pressures up to 38 bar, it ensures consistent performance even for containers with complex geometries. A “Clean Tech” system eliminates any risk of oil contamination in bottles — a crucial advantage for food and beverage applications where hygiene and purity are non-negotiable.

SHERIDAN, WYOMING – October 15, 2025 – Eli Lilly’s investigational oral GLP-1 receptor agonist, orforglipron, has achieved another major milestone in its late-stage clinical program. Following its earlier success against Novo Nordisk’s semaglutide, the once-daily oral therapy has now demonstrated superiority over AstraZeneca’s blockbuster Farxiga (dapagliflozin) in two Phase III studies targeting patients with inadequately controlled type 2 diabetes.

Strong Phase III Results Reinforce Competitive Edge
The twin trials, ACHIEVE-2 and ACHIEVE-5, assessed orforglipron’s efficacy and safety in patients whose diabetes remained poorly controlled despite metformin therapy. Both studies met their primary and secondary endpoints, showing significant improvements in key glycemic markers and body weight after 40 weeks of treatment.

SHERIDAN, WYOMING – October 15, 2025 – Sarepta Therapeutics is pressing forward with its limb-girdle muscular dystrophy (LGMD) gene therapy, SRP-9003, despite a strategic pivot earlier this year toward small interfering RNA (siRNA) therapies and ongoing regulatory challenges. New late-stage data presented at the World Muscle Society Congress in Vienna suggest the therapy could still hold clinical and commercial potential—if Sarepta can navigate FDA scrutiny and rebuild trust in its gene therapy platform.

Promising Clinical Outcomes at WMS 2025
At the 30th annual World Muscle Society (WMS) meeting, Sarepta shared Phase III data from its EMERGENE trial evaluating SRP-9003 in 17 LGMD patients. The therapy, designed to restore beta-sarcoglycan expression—a key muscle-stabilizing protein—met its primary endpoint after 60 days of observation.